Reviews
Klin Onkol 1990; 3(2): 35-37.
Authors: Němec Jaroslav1990-04-15:Iphosphamid
Authors: Němec Jaroslav1990-04-15:Iphosphamid
Klin Onkol 1990; 3(2): 38-40.
Authors: Kopečný J.1990-04-15:Ethiological factors in ovarian carcinomas
Authors: Kopečný J.1990-04-15:Ethiological factors in ovarian carcinomas
Original articles
Klin Onkol 1990; 3(2): 41-43.
Authors: Eckschlager Tomáš, Koutecký Josef1990-04-15:Suprarenal gland carcinomas in children
Authors: Eckschlager Tomáš, Koutecký Josef1990-04-15:Suprarenal gland carcinomas in children
Klin Onkol 1990; 3(2): 44-49.
Authors: Žaloudík Jan, Rejthar Aleš, Mechl Zdeněk, Ghosh A.K.1990-04-15:HLA-D antigens and the progress of malignant melanoma
Authors: Žaloudík Jan, Rejthar Aleš, Mechl Zdeněk, Ghosh A.K.1990-04-15:HLA-D antigens and the progress of malignant melanoma
Klin Onkol 1990; 3(2): 50-52.
Authors: Munzarová M., Kovařík Jan, Pačovský Zdeněk, Lorenz Ivan1990-04-15:Non-specific active immunotherapy with the BCG vaccine in patients with breast carcinoma. Evaluation after 7 year follow-up
Authors: Munzarová M., Kovařík Jan, Pačovský Zdeněk, Lorenz Ivan1990-04-15:Non-specific active immunotherapy with the BCG vaccine in patients with breast carcinoma. Evaluation after 7 year follow-up
Klin Onkol 1990; 3(2): 53-55.
Authors: Šmérková N., Nekulová Miroslava, Šakalová J.1990-04-15:The follow up of alfa1-antitrypsin concentration, alfa1-acid glykoprotein and prealbumin in patients with malignant breast cancer
Authors: Šmérková N., Nekulová Miroslava, Šakalová J.1990-04-15:The follow up of alfa1-antitrypsin concentration, alfa1-acid glykoprotein and prealbumin in patients with malignant breast cancer
Short Communications
Klin Onkol 1990; 3(2): 56-58.
Authors: Sieghart S.1990-04-15:Clinical experiences with Clodronate
Authors: Sieghart S.1990-04-15:Clinical experiences with Clodronate
Klin Onkol 1990; 3(2): 58-60.
Authors: Mechl Zdeněk1990-04-15:Anandron
Authors: Mechl Zdeněk1990-04-15:Anandron
Klin Onkol 1990; 3(2): 60.
Authors: Giona F., Testi A.M., Amadori S.1990-04-15:Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphoblastic leukemia
Authors: Giona F., Testi A.M., Amadori S.1990-04-15:Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphoblastic leukemia
Klin Onkol 1990; 3(2): 60-61.
Authors: Cummings B.J.1990-04-15:The treatment of anal carcinoma
Authors: Cummings B.J.1990-04-15:The treatment of anal carcinoma
Klin Onkol 1990; 3(2): 61.
Authors: Hiddemann Wolfgang, Kreutzmann H., Donhuijsen-Ant R.1990-04-15:High dose cytosine-arabinoside and mitoxantrone (HAM) for the treatment of refractory acute lymphoblastic leukemia
Authors: Hiddemann Wolfgang, Kreutzmann H., Donhuijsen-Ant R.1990-04-15:High dose cytosine-arabinoside and mitoxantrone (HAM) for the treatment of refractory acute lymphoblastic leukemia